NANOINNOVATIONS, LLC

Medtech · Private

AI-based predictive algorithm analyzing salivary metabolome and proteome to predict COVID-19 severity at diagnosis

Grants
$267K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: An Artificial Intelligence (AI)-based algorithm using nanosensor-based salivary analytics to predict clinical outcomes in symptomatic COVID-19 patients$267,239
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2266BIACURE THERAPIES, INC.——
2267LENA BIOSCIENCES, INC.——
2268Forsagen LLC——
2269NANOINNOVATIONS, LLC——
2270SILICON BIODEVICES, INC.——
2271VISIONQUEST BIOMEDICAL, LLC——
2272ADVANCED MRI TECHNOLOGIES LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.